SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001193125-24-269008
Filing Date
2024-12-02
Accepted
2024-12-02 17:04:51
Documents
4

Document Format Files

Seq Description Document Type Size
1 POS AM d868145dposam.htm POS AM 243357
2 EX-23.1 d868145dex231.htm EX-23.1 1421
3 GRAPHIC g868145g1127072158542.jpg GRAPHIC 1784
4 GRAPHIC g868145g53z69.jpg GRAPHIC 35158
  Complete submission text file 0001193125-24-269008.txt   297010
Mailing Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010 (212) 547-9879
Lexeo Therapeutics, Inc. (Filer) CIK: 0001907108 (see all company filings)

IRS No.: 854012572 | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-278566 | Film No.: 241519985
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)